Literature DB >> 27503288

Identification of susceptibility gene associated with female primary Sjögren's syndrome in Han Chinese by genome-wide association study.

I-Wen Song1, Hsiang-Cheng Chen2, Yuh-Feng Lin3,4, Jenn-Hwai Yang1, Chi-Ching Chang5, Chung-Tei Chou6, Ming-Ta Michael Lee1,7, Yi-Chun Chou1, Chien-Hsiun Chen1,8, Yuan-Tsong Chen1,9, Chen-Hung Chen10,11, Jer-Yuarn Wu12,13.   

Abstract

Primary Sjögren's syndrome (PSS) is an autoimmune disease targeting exocrine glands. It ten times more dominantly affects women than men with an onset peak at menopause. The genetic factor predisposing women to PSS remains unclear. Therefore, we aimed to identify susceptibility loci for PSS in women. We performed genome-wide association study (GWAS) using 242 female PSS patients and 1444 female control in Han Chinese population residing in Taiwan. Replication was conducted in an independent cohort of 178 female PSS and 14,432 control subjects. We identified rs117026326 on GTF2I with GWAS significance (P = 1.10 × 10-15) and rs13079920 on RBMS3 with suggestive significance (P = 2.90 × 10-5) associating with PSS in women. The association of RBMS3 was further evidenced by imputation in which rs13072846 (P = 4.89 × 10-5) was identified and confirmed as female PSS associating SNP within the same LD with rs13079920. PSS pathogenesis involves both immune (effector) and exocrine (target) system. We suggested that while GTF2I is a previously reported associating gene which may function in immune system, RBMS3 is a novel susceptibility gene that predisposes women to PSS potentially through modulating acinar apoptosis and TGF-β signaling in target exocrine system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27503288     DOI: 10.1007/s00439-016-1716-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  41 in total

1.  Economic and quality of life impact of dry eye symptoms in women with Sjögren's syndrome.

Authors:  R M Sullivan; J M Cermak; A S Papas; M R Dana; D A Sullivan
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

2.  A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls.

Authors:  S Taiym; N Haghighat; I Al-Hashimi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2004-05

3.  Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.

Authors:  S T Valtysdóttir; L Wide; R Hällgren
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

4.  Effect of nandrolone decanoate on Sjögren's syndrome like disorders in NZB/NZW mice.

Authors:  L P Schot; H A Verheul; A H Schuurs
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

Review 5.  All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.

Authors:  Fernand Labrie
Journal:  J Steroid Biochem Mol Biol       Date:  2014-06-09       Impact factor: 4.292

6.  Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.

Authors:  C P Robinson; S Yamachika; C E Alford; C Cooper; E L Pichardo; N Shah; A B Peck; M G Humphreys-Beher
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 7.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

8.  Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.

Authors:  Helena Forsblad-d'Elia; Hans Carlsten; Fernand Labrie; Yrjö T Konttinen; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

9.  Genotype imputation with thousands of genomes.

Authors:  Bryan Howie; Jonathan Marchini; Matthew Stephens
Journal:  G3 (Bethesda)       Date:  2011-11-01       Impact factor: 3.154

10.  Growth Arrest-Specific 6 Protein in Patients with Sjögren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary Gland.

Authors:  Chen-Hung Chen; Hsiang-Cheng Chen; Chi-Ching Chang; Yi-Jen Peng; Chien-Hsing Lee; Yi-Shing Shieh; Yi-Jen Hung; Yuh-Feng Lin
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

View more
  15 in total

Review 1.  Pathophysiology of TFII-I: Old Guard Wearing New Hats.

Authors:  Ananda L Roy
Journal:  Trends Mol Med       Date:  2017-04-28       Impact factor: 11.951

Review 2.  A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome.

Authors:  Lourdes Ortíz-Fernández; Javier Martín; Marta E Alarcón-Riquelme
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-24       Impact factor: 8.667

Review 3.  Contributions of Major Cell Populations to Sjögren's Syndrome.

Authors:  Richard Witas; Shivai Gupta; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.241

4.  Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.

Authors:  L A Aqrawi; M Ivanchenko; A Björk; J I Ramírez Sepúlveda; J Imgenberg-Kreuz; M Kvarnström; P Haselmayer; J L Jensen; G Nordmark; K Chemin; K Skarstein; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

5.  Genetics and epigenetics in primary Sjögren's syndrome.

Authors:  Juliana Imgenberg-Kreuz; Astrid Rasmussen; Kathy Sivils; Gunnel Nordmark
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580

Review 6.  The Role of Interferons in the Pathogenesis of Sjögren's Syndrome and Future Therapeutic Perspectives.

Authors:  Nicoletta Del Papa; Antonina Minniti; Maurizio Lorini; Vincenzo Carbonelli; Wanda Maglione; Francesca Pignataro; Nicola Montano; Roberto Caporali; Claudio Vitali
Journal:  Biomolecules       Date:  2021-02-09

7.  HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome.

Authors:  Gabriela Hernández-Molina; José Manuel Rodríguez-Pérez; Javier Fernández-Torres; Guadalupe Lima; Nonanzit Pérez-Hernández; Alberto López-Reyes; Gabriela Angélica Martínez-Nava
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

8.  Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis.

Authors:  Anna Tyler; J Matthew Mahoney; Gregory W Carter
Journal:  G3 (Bethesda)       Date:  2020-01-07       Impact factor: 3.154

9.  Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Chi-Ching Chang; Jin-Hua Chen; Pei-I Kuo; Tzu-Min Lin; Yu-Sheng Chang; Tsung-Yun Hou; Hui-Ching Hsu; Sheng-Hong Lin; Wei-Sheng Chen; Yi-Chun Lin; Li-Hsuan Wang
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

10.  Association of GTF2I gene polymorphisms with renal involvement of systemic lupus erythematosus in a Chinese population.

Authors:  Yanming Meng; Yao He; Junlong Zhang; Qibing Xie; Min Yang; Yuning Chen; Yongkang Wu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.